CEO of Siemens Healthcare Diagnostics appointed to AdvaMed Dx board

Michael Bassett | | Health Imaging | Artificial Intelligence
Donal Quinn, CEO of Siemens Healthcare Diagnostics, has been appointed to the board of the newly formed AdvaMed Dx, a division of the Advanced Medical Technology Association.

Quinn joins an 18 member board comprised of executives from various diagnostic companies. AdvaMed Dx was formed to advance public policy priorities of AdvaMed’s diagnostic member companies.

Michael Bassett,

Contributor

Related Content

New AI program delivers rapid, accurate echo video assessments
Do large language models help or hinder workflows related to radiology reports?
Hospital creates 'virtual reality technologist' role to support patients during interventional procedures
Radiomics model links brain MRI features with neuropsychological changes in Crohn's disease
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage
Routine abdominal CTs offer insight into cardiovascular risk

Around the web

Cardiovascular Business
New AI program delivers rapid, accurate echo video assessments

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

Cardiovascular Business
Philips, Mayo Clinic using AI to improve cardiac MRI technology

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.